Antibody-Drug Conjugates (ADCs) are targeted cancer therapies combining monoclonal antibodies and potent drugs. Their production is challenging, especially purification, due to ADC heterogeneity and stability concerns. To ensure purity, stability, and regulatory compliance, advanced bioprocessing tools like high-precision flow meters, single-use in-line pH sensors, and highly accurate temperature sensors are essential for rigorous process monitoring and control.
